Announcements Trials
Browse Landscape

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 2Myeloid 2Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Renal Insufficiency, Chronic 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Non-alcoholic Fatty Liver Disease 1Multiple Sclerosis 1Liver Cirrhosis, Biliary 1Irritable Bowel Syndrome 1Inflammatory Bowel Diseases 1Hepatitis 1Gastritis 1Fibrosis 1Exocrine Pancreatic Insufficiency 1Dyslipidemias 1Diabetes Mellitus 1Cystic Fibrosis 1Crohn Disease 1Chronic Pain 1Chronic Disease 1Cholelithiasis 1Cholecystitis 1Celiac Disease 1Arthritis, Rheumatoid 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phlebotomy × Gastrointestinal × 1 year × Clear all
NCT04306939 2026-01-07

GREAT1

University of Pittsburgh

Suspended
120,000 enrolled
Gastrointestinal

Arthritis, Rheumatoid, Celiac Disease, Cholecystitis, Cholelithiasis, Chronic Disease, Crohn Disease, Cystic Fibrosis, Diabetes Mellitus, Fibrosis, Gastritis, Hepatitis, Liver Cirrhosis, Biliary, Multiple Sclerosis, Pancreatic Cyst, Exocrine Pancreatic Insufficiency, Pancreatitis, Inflammatory Bowel Diseases, Irritable Bowel Syndrome, Dyslipidemias, Pancreatitis, Chronic, Renal Insufficiency, Chronic, Chronic Pain, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡